Skip to main content
. 2021 May 8;28(3):1773–1789. doi: 10.3390/curroncol28030165

Table 1.

Comparison of individuals who visited the Urgent Cancer Care Clinic (UCC) or an emergency department (ED) by follow-up period, 2013–2016, Winnipeg, Manitoba (N = 13,252 visits).

Variables UCC Visits, No. (%) ED Visits, No. (%)
Follow-Up Period Follow-Up Period
1 to 6 (N = 1358) 7 to 12 (N = 959) 13 to 18 (N = 531) 19 to 24 (N = 304) 1 to 6 (N = 4203) 7 to 12 (N = 2491) 13 to 18 (N = 1943) 19 to 24 (N = 1463)
Chemotherapy status at time of visit
Active 921 (68) 485 (51) 178 (34) 109 (36) 1147 (27) 669 (27) 282 (15) 176 (12)
Inactive 93 (7) 330 (34) 250 (47) 136 (45) 180 (4) 590 (24) 711 (37) 575 (39)
None 344 (25) 144 (15) 103 (19) 59 (19) 2876 (68) 1232 (49) 950 (49) 712 (49)
Radiation therapy status at time of visit
Active 305 (22) 163 (17) 43 (8) 13 (4) 423 (10) 137 (6) 63 (3) 43 (3)
Inactive 105 (8) 273 (28) 212 (40) 142 (47) 280 (7) 730 (29) 674 (35) 554 (38)
None 948 (70) 523 (55) 276 (52) 149 (49) 3500 (83) 1624 (65) 1206 (62) 866 (59)
Hormone therapy status at time of visit
Active 35 (2) 80 (8) 37 (7) 16 (5) 115 (3) 142 (6) 142 (7) 116 (8)
Inactive 12 (1) 42 (4) 25 (5) 23 (8) 70 (2) 184 (7) 181 (9) 199 (14)
None 1314 (97) 837 (87) 469 (88) 265 (87) 4018 (96) 2165 (87) 1620 (83) 1148 (78)
Immunotherapy status at time of visit
Active 175 (13) 115 (12) 66 (12) 29 (10) 191 (5) 111 (4) 97 (5) 52 (4)
Inactive 18 (1) 50 (5) 70 (13) 60 (20) 21 (1) 89 (4) 118 (6) 121 (8)
None 1165 (86) 794 (83) 395 (74) 215 (71) 3991 (95) 2291 (92) 1728 (89) 1290 (88)
Site
Hematologic 299 (22) 177 (18) 123 (23) 76 (25) 535 (13) 295 (12) 245 (13) 176 (12)
Genitourinary 148 (11) 110 (11) 96 (18) 78 (26) 677 (16) 518 (21) 411 (21) 364 (25)
Lung and bronchus 215 (16) 173 (18) 84 (16) 34 (11) 807 (19) 333 (13) 239 (12) 156 (11)
Breast 280 (20) 239 (25) 56 (11) 34 (11) 487 (11) 339 (14) 260 (13) 218 (15)
Digestive 279 (21) 171 (18) 86 (16) 49 (16) 1170 (28) 666 (27) 493 (25) 337 (23)
Other 137 (10) 89 (9) 86 (16) 33 (11) 527 (13) 340 (14) 295 (15) 212 (14)
Stage
I 124 (9) 107 (11) 46 (9) 25 (8) 585 (14) 426 (17) 376 (19) 324 (22)
II 256 (19) 229 (24) 85 (16) 82 (27) 728 (17) 557 (22) 471 (24) 378 (26)
III 345 (25) 240 (25) 122 (23) 70 (23) 818 (19) 562 (23) 397 (20) 326 (22)
IV 433 (32) 259 (27) 168 (32) 63 (21) 1437 (34) 620 (25) 394 (20) 242 (17)
Unknown 200 (15) 124 (13) 110 (21) 64 (21) 635 (15) 326 (13) 305 (16) 193 (13)
Age at diagnosis (mean (SD)) 61 (12) 62 (12) 62 (12) 60 (13) 67 (14) 66 (14) 66 (14) 67 (14)
Sex
Male 550 (41) 345 (36) 286 (54) 140 (46) 2036 (48) 1272 (51) 1003 (52) 677 (46)
Female 808 (60) 614 (64) 245 (46) 164 (54) 2167 (52) 1219 (49) 940 (48) 786 (54)
Income quintile (Q)
Q1 (lowest) 282 (21) 180 (19) 87 (16) 53 (17) 1147 (25) 663 (27) 482 (25) 339 (23)
Q2 264 (19) 198 (21) 88 (17) 62 (20) 803 (19) 509 (20) 383 (20) 332 (23)
Q3 294 (22) 185 (19) 128 (24) 82 (27) 850 (20) 460 (18) 364 (19) 292 (20)
Q4 286 (21) 218 (23) 128 (24) 44 (14) 777 (18) 457 (18) 407 (21) 282 (19)
Q5 (highest) 232 (17) 178 (19) 100 (19) 63 (21) 726 (17) 402 (16) 307 (16) 218 (15)
Residential mobility a
Low 1268 (93) 903 (94) 497 (94) 264 (87) 3819 (91) 2283 (92) 1780 (92) 1338 (91)
High 90 (7) 56 (6) 34 (6) 40 (13) 384 (9) 208 (8) 163 (8) 125 (9)
Continuity of care b
Yes (≥50%) 936 (69) 648 (68) 364 (69) 221 (73) 2993 (71) 1761 (71) 1336 (69) 1024 (70)
No (<50%) 312 (23) 230 (24) 119 (22) 54 (18) 854 (20) 553 (22) 445 (23) 314 (21)
<3 visits 110 (8) 81 (8) 48 (9) 29 (10) 356 (8) 177 (7) 162 (8) 125 (9)
Emergency department visits in 3 months prior to diagnosis
0 847 (62) 634 (66) 361 (68) 204 (67) 2243 (53) 1507 (61) 1172 (60) 963 (66)
1 288 (21) 212 (22) 106 (20) 68 (22) 1100 (26) 571 (23) 472 (24) 281 (19)
2 or more 223 (16) 113 (12) 64 (12) 32 (11) 860 (20) 413 (17) 299 (15) 219 (15)
Primary care clinician visits
Median (IQR) 6 (3–10) 6 (3–10) 6 (3–10) 6 (3–10) 7 (3–12) 7 (4–12) 7 (4–13) 8 (4–14)
Comorbidity (resource use band)
0, 1, 2 288 (21) 208 (22) 101 (19) 55 (18) 740 (18) 395 (16) 321 (17) 235 (16)
3 810 (60) 585 (61) 318 (60) 186 (61) 2377 (57) 1406 (56) 1096 (56) 788 (54)
4, 5 260 (19) 166 (17) 112 (21) 63 (21) 1086 (26) 690 (28) 526 (27) 440 (30)
Canadian Triage Acuity Score (CTAS)
1, 2 338 (25) 197 (21) 94 (18) 54 (18) 1081 (26) 674 (27) 495 (25) 361 (25)
3, 4, 5 914 (67) 706 (74) 403 (76) 229 (75) 3115 (74) 1814 (73) 1441 (74) 1098 (75)
Unknown 106 (8) 56 (6) 34 (6) 21 (7) 7 (0) 3 (0) 7 (0) 4 (0)
Days between diagnosis and ED/UCC visit
Median (IQR) 105 (67–140) 249 (211–295) 428 (394–483) 615 (576–670) 70 (27–121) 263 (219–307) 443 (400–493) 624 (580–674)
Days between diagnosis and start of eligibility
Median (IQR) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
Hours between triage and discharge
Median (IQR) 2 (1–3) 2 (1–3) 2 (1–3) 2 (1–3) 9 (5–20) 9 (5–19) 9 (5–19) 8 (5–18)
Hours between triage and exam room
Median (IQR) 1 (1–2) 1 (1–2) 1 (1–2) 1 (1–2) NA NA NA NA

Abbreviations: UCC, urgent cancer care; ED, emergency department; IQR, interquartile range; NA, not available. a Residential mobility included postal code changes in the 5 years prior to diagnosis. b Continuity of care included primary care clinician visits in the 6 to 30 months prior to diagnosis.